DNA analysis and persistent hypercalcitoninemia in medullary thyroid carcinoma

Area of Science:

• Oncology
• Genetics
• Endocrinology

Background:

• Medullary thyroid carcinoma (MTC) is a rare thyroid malignancy.
• Prognostic factors for MTC, including DNA content and serum calcitonin, require further investigation.

Purpose of the Study:

• To evaluate the correlation between DNA content, postoperative serum calcitonin, and patient survival in medullary thyroid carcinoma.
• To determine the optimal surgical approach and management strategy for MTC.

Main Methods:

• Retrospective review of clinical data from 20 medullary thyroid carcinoma patients treated between 1970 and 1991.
• Analysis of DNA content in tumor tissue and postoperative serum calcitonin levels.
• Comparison of survival rates, recurrence, and metastatic patterns based on treatment and tumor characteristics.

Main Results:

• Aneuploid DNA was observed in all three patients with stage IV disease, who died within 7 months (average survival 4 months).
• Total thyroidectomy was associated with a lower reoperation rate for tumor recurrence compared to less than total thyroidectomy.
• Persistent postoperative hypercalcitoninemia without demonstrable lesions did not necessitate reoperation and patients remained well.
• Aneuploid MTC cases showed a trend towards more advanced disease and higher rates of metastatic lesions compared to diploid cases.

Conclusions:

• Total thyroidectomy is the preferred surgical treatment for medullary thyroid carcinoma.
• Conservative management of persistent postoperative hypercalcitoninemia without clinical lesions is a viable option.
• DNA aneuploidy is not a reliable indicator for assessing the grade of malignancy in medullary thyroid carcinoma.